U2AF1 and myelodysplastic syndrome: In summary, our results show that VAF > 40% of U2AF1 is an independent factor of short OS in MDS patients, and the OS of MDS patients with Q157 mutation of U2AF1 was shortened, but the difference was not significant, which needs to be further verified in the future.